Cargando…
Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
Antibody-mediated rejection (AMR) remains a refractory rejection after donor-specific antibody (DSA)-positive or blood-type incompatible liver transplantation (LT), even in the era of pre-transplant rituximab desensitization. This is due to the lack of not only effective post-transplant treatments b...
Autores principales: | Tajima, Tetsuya, Hata, Koichiro, Kusakabe, Jiro, Miyauchi, Hidetaka, Badshah, Joshua Sam, Kageyama, Shoichi, Zhao, Xiangdong, Kim, Sung-Kwon, Tsuruyama, Tatsuaki, Kirchner, Varvara A., Watanabe, Takeshi, Uemoto, Shinji, Hatano, Etsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313232/ https://www.ncbi.nlm.nih.gov/pubmed/37398677 http://dx.doi.org/10.3389/fimmu.2023.1186653 |
Ejemplares similares
-
Properdin inhibition ameliorates hepatic ischemia/reperfusion injury without interfering with liver regeneration in mice
por: Kusakabe, Jiro, et al.
Publicado: (2023) -
Complement-5 Inhibition Deters Progression of Fulminant Hepatitis to Acute Liver Failure in Murine Models
por: Kusakabe, Jiro, et al.
Publicado: (2021) -
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022) -
Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019) -
Prognostic index consisting of early post‐transplant variables <2 weeks in adult living‐donor liver transplantation
por: Kusakabe, Jiro, et al.
Publicado: (2020)